Home › Gastrointestinal Cancers › Texas › Irving
Gastrointestinal Cancers clinical trials in Irving, TX
3 studies for Gastrointestinal Cancers are looking for participants at sites in and around Irving (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- US Oncology Investigational Products Center (IPC), Irving
- US Oncology Investigational Products Center, Irving
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RecruitingPhase 1/2
- NEXT Oncology Dallas, Irving
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
- NEXT Dallas, Irving
Gastrointestinal Cancers trials in other cities
- Houston, TX21 studies
- Boston, MA15 studies
- New York City, NY12 studies
- Nashville, TN11 studies
- Los Angeles, CA10 studies
- Arlington, VA8 studies
- Durham, NC8 studies
- Baltimore, MD8 studies
- Dallas, TX8 studies
- Baldwin Park, CA7 studies
- Cincinnati, OH7 studies
- Seattle, WA7 studies
Other studies in Irving
- Non-Small Cell Lung Cancer23 studies
- Colorectal Cancer15 studies
- Cancer (all types)14 studies
- Metastatic Cancer10 studies
- Stomach Cancer9 studies
- Head and Neck Squamous Cell Carcinoma8 studies
- Breast Cancer8 studies
- Pancreatic Cancer7 studies
- Ovarian Cancer7 studies
- Small Cell Lung Cancer6 studies
- Endometrial Cancer6 studies
- Esophageal Cancer5 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.